002880 卫光生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.29811.3436.51112.18312.480
总资产报酬率 ROA (%)1.5858.0205.13210.70111.129
投入资产回报率 ROIC (%)1.7638.8095.56411.69911.293

边际利润分析
销售毛利率 (%)43.27841.32036.06840.87537.183
营业利润率 (%)24.47123.58720.68626.64024.392
息税前利润/营业总收入 (%)26.41624.60120.33825.93323.421
净利润/营业总收入 (%)20.67820.74818.14722.59020.959

收益指标分析
经营活动净收益/利润总额(%)98.13090.60780.08996.76096.135
价值变动净收益/利润总额(%)0.0003.02813.6050.3050.000
营业外收支净额/利润总额(%)-0.070-0.755-0.619-0.235-0.732

偿债能力分析
流动比率 (X)3.8294.1494.9325.9796.080
速动比率 (X)1.6221.6192.2963.4563.999
资产负债率 (%)31.01728.89127.49310.74311.566
带息债务/全部投入资本 (%)22.13018.18321.3190.264--
股东权益/带息债务 (%)338.436432.487359.39536,801.5062,729.583
股东权益/负债合计 (%)219.074242.351259.953821.783755.217
利息保障倍数 (X)13.46420.649-92.217-40.235-29.512

营运能力分析
应收账款周转天数 (天)25.41827.16762.31546.7450.000
存货周转天数 (天)490.385374.036432.981270.2730.000